Skip to main content

Canada Trudeau pledges access to medication as pharmacists, patient groups fear shortage

Canadians will continue to have access to the medications they need, Prime Minister Justin Trudeau promised Thursday in the face of escalating worry about a Trump administration decision to allow prescription drug imports from Canada.

During a visit to Iqaluit, Mr. Trudeau said Health Canada already ensures there is a “steady and solid supply” of medications for Canadians regardless of external or international pressures. He did not, however, mention drug-shortage challenges that already exist.

How national pharmacare could change what Canadians spend on prescriptions

“We recognize the new situation brought on by American announcements and Health Canada will continue to ensure that our priority is always ensuring that Canadians have access to the medication they need at affordable prices,” he said.

Story continues below advertisement

On Wednesday, the U.S. administration revealed a proposal aimed at allowing American patients to import cheaper medications from outside the country, under the oversight of the Food and Drug Administration.

The American proposal would allow states, wholesalers and pharmacists to get the FDA approval to import certain medications that are also available in the United States, although few other details were released.

Canada was not consulted on the specifics of the plan ahead of time, officials confirmed Wednesday.

The office of Health Minister Ginette Petitpas Taylor said while it remains in regular contact with counterparts from the U.S. Department of Health and Human Services about their “mutual interest” in fostering lower drug prices, details of the surprise announcement were not discussed beforehand.

The U.S. decision on Wednesday was met by sharp criticism from several groups in Canada, including the Canadian Pharmacists Association, which warned the Canadian supply cannot support consumers on both sides of the border. It also warned of worsening drug shortages in Canada and disrupted access to medications.

John Adams, the volunteer chairman of the Best Medicines Coalition, a non-profit organization representing 28 national patient organizations, called the proposal a “clear and present danger” to the health and well-being of Canadians who need prescription medications.

On Thursday, opposition health critics urged the federal government to take the threat seriously.

Story continues below advertisement

“When Canadians visit their pharmacist for the medicine they depend on, it should be available,” Conservative MP Marilyn Gladu said in a statement.

NDP MP Don Davies urged the Liberals to detail their plans to protect Canada’s drug supply.

“We need a plan and we need a strategy that can tell Canadians exactly how this government is going to make sure that Canadians have an adequate stock pile of all necessary medication,” Mr. Davies said.

“I’m not hearing that plan. I’m just hearing vague assurances ... that’s not good enough when we are talking life-saving medication.”

Mr. Davies also said he is contemplating whether to engage the House of Commons health committee to possibly recall Parliament to deal with the issue.

“I’m taking the situation very seriously and I’m not seeing the government do the same.”

Story continues below advertisement

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter